11 results

• FDA Issues Draft Guidance On Conducting Safety Trials For New Diabetes Drugs

  March 12, 2020

  Russell Maas

  A draft guidance seeks to require broader clinical trials for diabetes drugs, in an effort to better identify potential adverse health effects before they receive FDA approval.

• Some Diabetes Drugs Side Effects May Have Toxic Effects On Mitochondria, Causing Heart Problems: Study

  September 26, 2019

  Martha Garcia

  A new study indicates diabetes drugs like Avandia may cause heart problems through mitochondrial toxicity, which could be preventable through the use of other medications.

• Study Finds Little Difference Between Diabetes Drugs’ Effectiveness

  July 27, 2016

  Irvin Jackson

  The findings of a new study suggest that there is little difference between a variety of diabetes drugs currently on the market, despite a wide range of risks.

• Bill Would Make It Illegal To Cover Up Dangerous Defects and Side Effects

  July 17, 2014

  Irvin Jackson

  Recently proposed legislation would make it illegal for corporate officers to cover up dangerous product defects or drug side effects, putting in place fines and jail terms for executives.

• Lawsuits Show Pattern of Drug Companies Hiding Side Effects: Report

  February 7, 2014

  Irvin Jackson

  Court records increasingly show that drug companies are waiting until they have maximized profits to reveal that their drugs are linked to dangerous side effects, according to a new report.

• Metformin May Increase Heart Failure Risk in Men: Study

  December 20, 2013

  Irvin Jackson

  The diabetes drug Metformin appears to affect men and women's hearts differently, according to a new study that raises questions about gender differences in a number of diabetes drugs.

• Sulphonylurea Diabetes Drugs May Increase Heart Attack Risk: Study

  September 19, 2013

  Irvin Jackson

  An older class of diabetes drugs has been linked to heart problems following a clincal study to confirm long-held fears.

• New J&J Medication, Invokana, Hopes To Break Diabetes Drug Curse

  April 11, 2013

  Irvin Jackson

  Johnson & Johnson has high hopes that its recently approved diabetes drug, Invokana, will break the trend of problems that...

• FDA Should Define Role in Protecting Clinical Trial Participants: Report

  August 24, 2012

  Martha Garcia

  Researchers are calling for federal regulators to take a new look at the ethics behind post-marketing trials, which often involve...

• Keppra Stevens-Johnson Syndrome Risk Being Evaluated by FDA

  February 2, 2011

  Staff Writers

  Federal drug safety reviewers are evaluating the potential risk of rare and sometimes fatal skin reactions known as Stevens-Johnson Syndrome...